Previous close | 71.00 |
Open | 71.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 71.00 - 71.00 |
52-week range | 50.00 - 80.00 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 06 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its portfolio of cell and gene therapy workflow solutions at the upcoming annual meeting of the American Society of Gene & Cell Therapy (ASGCT), taking place May 7-11, 2024, in Baltimore, Maryland.
Bio-Techne Corporation ( NASDAQ:TECH ) defied analyst predictions to release its quarterly results, which were ahead of...
Key Insights Using the 2 Stage Free Cash Flow to Equity, Bio-Techne fair value estimate is US$50.46 Bio-Techne is...